VYSCOXA
NDC 15370-501, Celecoxib, suspension, from Carwin Pharmaceutical Associates, LLC.
- Product NDC
- 15370-501
- Status
- Listed
- Labeler
- Carwin Pharmaceutical Associates, LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA211759
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/15370-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CELECOXIB10 mg/mL
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 15370-501-16 | 15370050116 | 473 mL in 1 BOTTLE (15370-501-16) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5094d47e-f791-4190-9397-b7500143a74d
Use it
Look up 15370-501 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/15370-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 15370-501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.